IQV

IQVIA Holdings Inc. Common Stock (IQV)

Stock · NYSE · Health Care

$261.75as of 8/28/2026

AI Market Commentary

AI-generated

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

August 28, 2026

IQVIA Draws Attention as Analysts Weigh Outlook After Strong Run. IQVIA recently appeared in market coverage discussing analyst sentiment and broader healthcare peer performance, with one article noting a 33.3% monthly gain in a comparable stock. A separate piece examined whether Wall Street is leaning bullish or bearish on IQVIA's near-term outlook. Together, the coverage reflects heightened investor focus on the stock following its recent strength, as the company sits near a well-tested support level of $163.42 and shows an elevated RSI reading, signals readers can view on the chart alongside this commentary.

Active signals

Support level
$163.42
Industry
Biotechnology: Commercial Physical & Biological Resarch

About IQV

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud…

Sector
Health Care
Industry
Biotechnology: Commercial Physical & Biological Resarch
Employees
94,000

Fundamentals

1-day range
$258.08$262.78
Market cap
$38.41B
P/E (trailing)
28.64
P/E (forward)
18.10
EPS (trailing)
$8.07
Dividend yield
Beta
1.19
Avg. volume
1.45M
52-week range
$154.5$265.25
Next earnings: November 3, 2026 · EPS estimate $3.27Before Openconfirmed

How IQVIA Holdings Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$16.31BNet Income$1.36B (8%)Other$12.70B (78%)SG&A$2.00B (12%)Tax$252.00M (2%)IQV

Source: 10-K filed Feb 17, 2026 · via SEC EDGAR / Finnhub

Forecasts

18 analyst ratings

Buy 79%
Hold 21%
Sell 0%
1-year price forecast
High
$300
+14.6%
Median
$278
+6.2%
Low
$240
-8.3%

IQVIA Holdings Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • IQV
    IQVIA Holdings Inc. Common Stock
    $261.54
    ▼ 0.32%
    Market cap $38.41BP/E 28.64
    $154.5$265.25
  • INCY
    Incyte Corp. Common Stock
    $124.39
    ▼ 2.63%
    Market cap $24.01BP/E 15.14
    $81.09$132.6
  • MEDP
    Medpace Holdings Inc. Common Stock
    $599.99
    ▼ 1.89%
    Market cap $16.00BP/E 33.13
    $373$677.9
  • ICLR
    ICON plc Ordinary Shares
    $169.84
    ▲ 0.07%
    Market cap $12.13BP/E 183.55
    $66.57$203.91
  • CRL
    Charles River Laboratories International Inc. Common Stock
    $291.74
    ▼ 1.58%
    Market cap $11.12BP/E
    $144.26$303.31
  • ABSI
    Absci Corporation Common Stock
    $8.72
    ▼ 7.43%
    Market cap $1.24BP/E
    $2.24$12.06
  • ONMD
    OneMedNet Corp Class A Common Stock
    $0.5801
    ▼ 0.84%
    Market cap $43.24MP/E
    $0.49$4.22

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
156.9K
Disposed
169.1K

Institutional Ownership

March 31, 2026

Total shares held
142.73M
Total value held
$23.67B
Institutional holders
1055
Top holders this quarter
  • Unknown15.03M
  • Unknown12.18M
  • Unknown11.03M
  • Unknown7.48M
  • Unknown5.06M
  • Unknown4.46M
  • Unknown4.24M
  • Unknown3.26M
  • Unknown2.88M
  • Unknown2.61M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.